Evaluating Commonalities Across Medically Unexplained Symptoms.

Tytuł:: Evaluating Commonalities Across Medically Unexplained Symptoms.
Autorzy:: Guo D; Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria 3010, Australia. .
Kleinstäuber M; Department of Psychological Medicine, Dunedin Medical School, University of Otago, Dunedin 9016, New Zealand. .
Johnson MH; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand. .
Sundram F; Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand. .
Źródło:: International journal of environmental research and public health [Int J Environ Res Public Health] 2019 Mar 06; Vol. 16 (5). Date of Electronic Publication: 2019 Mar 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: Basel : MDPI, c2004-
MeSH Terms:: Medically Unexplained Symptoms*
Mental Disorders/*epidemiology
Somatoform Disorders/*epidemiology
Somatoform Disorders/*therapy
Comorbidity ; Culturally Competent Care ; Humans ; Physician-Patient Relations ; Quality of Life/psychology ; Somatoform Disorders/pathology ; Somatoform Disorders/psychology ; Treatment Outcome
References:: J Psychosom Res. 2011 Oct;71(4):282-3. (PMID: 21911108)
Semin Arthritis Rheum. 2008 Jun;37(6):339-52. (PMID: 18191990)
Curr Rheumatol Rev. 2015;11(2):96-108. (PMID: 26088211)
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):185-203. (PMID: 28108416)
Psychol Med. 2011 May;41(5):1099-107. (PMID: 20663256)
J Psychosom Res. 2004 Apr;56(4):409-12. (PMID: 15094024)
J Affect Disord. 2015 May 1;176:151-4. (PMID: 25721611)
Clin Gastroenterol Hepatol. 2007 May;5(5):556-62. (PMID: 17258513)
J Abnorm Psychol. 2008 May;117(2):300-313. (PMID: 18489206)
J Psychosom Res. 2016 Jan;80:1-10. (PMID: 26721541)
Int J Behav Med. 2012 Jun;19(2):165-73. (PMID: 21562781)
BMJ Open. 2014 Jun 12;4(6):e005374. (PMID: 24928596)
Soc Sci Med. 2003 Mar;56(5):1135-8. (PMID: 12593884)
Br J Gen Pract. 2015 Sep;65(638):e617-23. (PMID: 26324499)
Front Psychiatry. 2018 Nov 23;9:626. (PMID: 30532714)
Soc Psychiatry Psychiatr Epidemiol. 2001 Jun;36(6):287-93. (PMID: 11583458)
J Psychosom Res. 2001 Oct;51(4):549-57. (PMID: 11595242)
Aust N Z J Psychiatry. 2012 Nov;46(11):1053-7. (PMID: 22696549)
Colomb Med (Cali). 2016 Sep 30;47(3):155-159. (PMID: 27821895)
BMJ Open. 2018 Sep 19;8(9):e020775. (PMID: 30232103)
Brain Behav Immun. 2013 Jul;31:31-47. (PMID: 22580182)
Gastroenterology. 2016 Feb 18;:. (PMID: 27144624)
Clin Psychol Rev. 2007 Oct;27(7):781-97. (PMID: 17822818)
J Psychosom Res. 2015 Jun;78(6):546-52. (PMID: 25864805)
Gen Hosp Psychiatry. 2013 May-Jun;35(3):297-303. (PMID: 23219918)
Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):53-9. (PMID: 25456975)
J Affect Disord. 2011 Dec;135(1-3):111-4. (PMID: 21794924)
Br J Psychiatry. 2012 Jun;200(6):499-507. (PMID: 22539780)
Annu Rev Clin Psychol. 2010;6:257-83. (PMID: 20192784)
Adv Psychosom Med. 2013;33:64-74. (PMID: 23816864)
Aust Fam Physician. 2011 Jun;40(6):440-4. (PMID: 21655496)
Gen Hosp Psychiatry. 2008 May-Jun;30(3):191-9. (PMID: 18433651)
J Psychosom Res. 2010 May;68(5):395-7. (PMID: 20403497)
Asian J Psychiatr. 2018 Feb;32:99-104. (PMID: 29222988)
Front Cell Neurosci. 2015 Mar 31;9:40. (PMID: 25873859)
Soc Sci Med. 2005 Oct;61(7):1505-15. (PMID: 15922499)
Clin Psychol Rev. 2007 Oct;27(7):821-41. (PMID: 17716793)
Psychosom Med. 2017 Apr;79(3):345-357. (PMID: 27768649)
Front Psychiatry. 2018 Jun 26;9:240. (PMID: 29997528)
Aliment Pharmacol Ther. 2003 Mar 15;17(6):841-51. (PMID: 12641507)
J Psychosom Res. 2010 May;68(5):415-26. (PMID: 20403500)
Br J Gen Pract. 2003 Mar;53(488):231-9. (PMID: 14694702)
Psychosom Med. 2003 Jul-Aug;65(4):528-33. (PMID: 12883101)
Psychosom Med. 1988 Sep-Oct;50(5):510-9. (PMID: 3186894)
BMC Fam Pract. 2014 May 29;15:107. (PMID: 24885524)
Cult Med Psychiatry. 2000 Dec;24(4):431-52. (PMID: 11128626)
Soc Psychiatry Psychiatr Epidemiol. 2006 Sep;41(9):704-12. (PMID: 16794766)
Contributed Indexing:: Keywords: MUPS; MUS; anxiety; cognitive; culture; depression; emotional; medical consultation; medically unexplained physical symptoms; psychological; quality of life
Entry Date(s):: Date Created: 20190309 Date Completed: 20190626 Latest Revision: 20220410
Update Code:: 20240105
PubMed Central ID:: PMC6427368
DOI:: 10.3390/ijerph16050818
PMID:: 30845721
: Czasopismo naukowe

This commentary presents commonalities in medically unexplained symptoms (MUS) across multiple organ systems, including symptoms, aetiological mechanisms, comorbidity with mental health disorders, symptom burden and impact on quality of life. Further, treatment outcomes and barriers in the clinician⁻patient relationship, and cross-cultural experiences are highlighted. This discussion is necessary in aiding an improved understanding and management of MUS due to the interconnectedness underlying MUS presentations across the spectrum of medical specialties.

Comment in: Int J Environ Res Public Health. 2019 Apr 08;16(7):. (PMID: 30965593)

Informacja